Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease
Related Posts
Leung FW, Cadoni S, Chen L, Chen Y, Cheng CL, Cheung R, Dixit V, Elashoff D, Friedland S, Gallittu P, Hsieh YH, Cheng CH, Jacob[...]
Lacy BE, Shin AS, Cangemi DJ, Yang Y, Zhao S, Rosenbaum DP. Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post[...]
De Schepper S, Konstantellos V, Conway JA, Sokolova D, Zaccagnini L, Cowley MV, Sierksma A, Yudina M, Edmonds M, Gavriouchkina D, Geary B, Wallis A,[...]